sanscuba
5 years ago
Findit, Inc. Announces Second Topical CBD Purchase Orders From Same Two Major Retailers Weeks after Pilot Program Shipped
Press Release | 08/12/2019
ATLANTA, GA / ACCESSWIRE / August 12, 2019 / Findit, Inc. a Nevada Corporation (OTC PINK:FDIT) has received its second purchase orders from two major retailers for the CBD line Urban Collective. The purchase orders consist of four topical essential oils. Findit announced on July 23, 2019 it received its first orders for its CBD Topical Oil. The first orders were part of a pilot program to test the line out and monitor in store sales. With approximately 2,300 retail locations, they provided a second P.O. for approximately a fifty percent increase from the first order. The second order came in prior to the first order hitting the shelves. Revenues from the purchase orders will be booked in the third quarter, ending September 30, 2019. The combined P.O.s alone, currently increase revenue over the same quarter of 2018 without including Findit, Inc's online marketing services through August 12, 2019.
Clark St. Amant stated, "The additional P.O.s from the same two major retailers within weeks after our pilot program shipped, is a positive sign for Findit. We are taking meetings with other well known National Retailers to either carry our Urban Collective CBD line, or create a private label line for themselves. The upside of working B2B is that Findit is able to private label for each of our buyers in the event that is what they require. With our L.A. based branding and sales division being built out, the focus is to increase revenue while increasing profit margins across Findit's different revenue streams. We see the CBD space as one of these areas we can capitalize on both with B2B sales and our online marketing services."https://www.otcmarkets.com/stock/FDIT/news/Findit-Inc-Announces-Second-Topical-CBD-Purchase-Orders-From-Same-Two-Major-Retailers-Weeks-after-Pilot-Program-Shipped?id=236984
John-Knee
5 years ago
WeedMD to Expand Production with Outdoor Cannabis Cultivation at its Licensed 98-Acre Strathroy Property
2019-03-27 07:29:52 AM ET (GlobeNewswire)
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has applied for an amendment to its Strathroy licence to expand beyond its existing cultivation with an initial 25-acre, large-scale, low-cost, outdoor cannabis grow operation with the capacity to increase up to 50 acres. The Company confirms it has secured the support of the Municipality of Strathroy-Caradoc for its planned outdoor grow expected to be completed in two phases. In 2019, Phase I will be brought online, representing more than 25 acres of production, with an additional 25 acres planned for Phase II in 2020. Pending Health Canada approval, the outdoor grow is expected to increase WeedMD's total production footprint to upwards of 2.7 million square feet with the potential to yield over 100,000 kgs of cannabis in 2020 together with greenhouse cultivation.
WeedMD's outdoor grow will be situated on organically-certified* soil on its 98-acre Strathroy property which also houses the Company's 610,000 sq. ft. modern greenhouse facility. Outdoor grow video here.
"Our municipality is proudly home to a thriving agricultural community which has long supported our local businesses and we're pleased that WeedMD continues to expand its local footprint in a progressive and economically-viable manner," said Mayor Joanne Vanderheyden, Municipality of Strathroy-Caradoc. "We welcome and wholly support its push for outdoor expansion along with the job opportunities, sustainable cultivation and community engagement it will bring for the continued long-term growth of our municipality."
"In November 2017, we initially selected this 98-acre property in Strathroy because of its expansion potential, which included low-cost scalable outdoor production that is strategically located alongside our licensed state-of-the-art greenhouse propagation operations. WeedMD, with its proven cultivation team, genetics bank and propagation capabilities, has positioned itself as a first-mover in the industry," said Keith Merker, CEO of WeedMD. "With our outdoor grow site, we will continue producing cannabis products at an expected lower cost, in a supportive municipality that will complement our existing robust production platform with our first outdoor harvest expected in fall 2019."
"With the anticipated demand for extracted products and cannabis concentrates, our experienced cultivation team and proven outdoor grow genetics are expected to generate high yields at very low cost. The addition of an outdoor grow will ensure that WeedMD is positioned to meet the needs of its patients and customers in the ever-expanding cannabis market," said Derek Pedro, Chief Cannabis Officer of WeedMD. "Our methodologies and standardized innovative practices have been derived from more than 15 years of outdoor growing experience under Canada's legal cannabis programs. With cannabis plants being readied for transplant in June 2019, WeedMD is optimally positioned to rapidly scale production and is already being recognized as an industry-leader and expert in outdoor cultivation."
Highlights of WeedMD's Large-Scale, Low-Cost Outdoor Expansion
-- Phase I of the outdoor grow is more than 25 acres. Capable of producing more than 25,000 kgs of cannabis, WeedMD has already commenced retrofitting the highly-secured space and its first outdoor harvest is expected in fall 2019.
-- Phase II will bring the total outdoor grow to 50 acres in 2020. Increases WeedMD's total production footprint to over 2.7 million square feet with the potential to yield more than 100,000 kgs of cannabis in 2020.
-- Industry-leading production costs. With the cultivation of outdoor cannabis, WeedMD expects its production costs to be amongst the lowest in the industry.
-- Experienced leadership team with leading methodologies to revolutionize outdoor cultivation. WeedMD's skilled cultivation team is led by industry pioneer and Chief Cannabis Officer Derek Pedro who together have more than 40 years of combined outdoor, indoor and greenhouse cultivation experience.
-- Outdoor grow complements WeedMD's greenhouse cultivation in Strathroy. With the outdoor grow adjacent to its state-of-the-art 610,000 sq. ft. hybrid greenhouse facility in Strathroy, the Company can utilize existing, on-site storage and packaging as per Health Canada regulations. Also, WeedMD will leverage its existing site for its propagation, genetics and clones ahead of the outdoor growing season to take into account the longer growing period for its proprietary outdoor genetics.
-- Sustainable growing practices. Cultivated in a natural environment using sustainable growing practices such as direct sunlight, pre-tested live soil that is certified-organic*, onsite water reservoir, appropriate ventilation, natural bio-security practices and state-of-the-art irrigation mechanisms already in place, Strathroy is positioned to become the standard of excellence for outdoor cannabis cultivation.
* Organically-certified soil as accredited by the Centre for Systems Integration (CSI), a division of the Canadian Seed Institute.
UnderOath-KY
6 years ago
WeedMD To Absorb Excise Tax and Offer Free Shipping for Medical Cannabis Patients
GlobeNewswireSeptember 26, 2018, 7:35 AM EDT
TORONTO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to provide an update on its medical cannabis program and its dedication and responsibility to putting patients first.
Patients First Approach
Given the recent government announcements to impose an excise tax of $1 per gram (or 10% of the sale price) on cannabis (the “Excise Tax”), WeedMD is pleased to announce it will further support its medical-use customers by continuing to offer competitive pricing on its premium, medical-grade cannabis and that it will absorb the increased cost as a result of the Excise Tax. Scheduled to come into effect on October 17, 2018, the Excise Tax is applicable for both the recreational and the medical market on all cannabis products containing THC.
Additionally, effective immediately, the Company will be offering free standard shipping on all medical cannabis orders with no minimums and no restrictions. WeedMD also remains committed to its compassionate pricing program which supports patients that require financial assistance.
“Despite the fact that almost all prescription drugs are tax free in Canada, medical cannabis patients are being forced to pay the Excise Tax on their medicine. WeedMD is proud to demonstrate support for our patients by implementing these cost-relief initiatives and putting our patients first,” said Keith Merker, CEO of WeedMD. “The reality is that many patients do not have the cost of their medicine covered by insurance and often struggle to afford their prescriptions. Adding an additional tax could put their treatment further out of reach.”
WeedMD also urges all cannabis patients, industry advocates, and fellow Canadians to express their support for the removal of the Excise Tax on medical cannabis by signing Petition E-1528 (the “Petition”). Signatures for the Petition close October 17, 2018, the day the Excise Tax and adult-use legalization are scheduled to come into effect.
For more information, access WeedMD’s investor presentation here and recently updated corporate video here.
About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of cannabis and cannabis oil under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates two facilities: a 26,000 sq. ft. indoor facility in Aylmer, Ontario and a state-of-the-art greenhouse facility located in Strathroy, Ontario. The greenhouse currently has 44,000 square feet of licensed space in production and is expected to have a total footprint of more than 500,000 square feet online by year-end 2018. WeedMD has a multi-channeled distribution strategy that includes supply agreements with Shoppers Drug Mart and provincial distribution agencies, as well as through strategic relationships across the seniors' market in Canada.
User-65225
6 years ago
WeedMD Quote on the Blockstrain (DNAX.v/BKKSF) site now...
Investors in WeedMD are investors in Blockstrain, which is breaking out on strong volume. WeedMD bought a chunk of their stock... https://web.tmxmoney.com/quote.php?qm_symbol=dnax
“WeedMD has amongst the most robust and expansive library of genetics in the industry. After conducting an extensive review of the blockchain technologies being proposed for and utilized in the cannabis sector, we believe that BLOCKStrain is best positioned to protect our intellectual property by further validating and securing our best-in-class genetics,”
Derek Pedro, Design, Cultivation and Production Partner at WeedMD
https://blockstrain.io/
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Mygolfballs
3 years ago
JohnCM
4 years ago
TrendTrade2016
5 years ago
Cheetah SPEED
6 years ago
CaptStockWolf
6 years ago
Hot Features
Premium
